ClinicalTrials.gov
ClinicalTrials.gov Menu

Glasgow-Blatschford Score Validation in Digestive Hemorrhage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029626
Recruitment Status : Completed
First Posted : December 10, 2009
Last Update Posted : June 1, 2018
Sponsor:
Information provided by (Responsible Party):
Marc Girardin, University Hospital, Geneva

December 9, 2009
December 10, 2009
June 1, 2018
October 2009
June 2010   (Final data collection date for primary outcome measure)
Comparison of length of stay between patients with score equal to zero and above zero [ Time Frame: june 2010 ]
Same as current
Complete list of historical versions of study NCT01029626 on ClinicalTrials.gov Archive Site
Determination of the proportion of low risk upper gastrointestinal bleeding [ Time Frame: june 2010 ]
Same as current
Not Provided
Not Provided
 
Glasgow-Blatschford Score Validation in Digestive Hemorrhage
Glasgow-Blatschford Score Validation for Stratification of Patients With Digestive Hemorrhage
The purpose of this study is to validate the Glasgow-Blatchford score for the stratification of patients with upper gastro-intestinal hemorrhage. This score is easy to calculate. It is mainly based on the hemoglobin, blood pressure and blood urea. if the score is zero, the bleeding is very low risk and the gastrointestinal endoscopy may be delayed and performed as an outpatient.
Not Provided
Interventional
Not Applicable
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Gastrointestinal Hemorrhage
Procedure: Endoscopy
Realization of an upper GI endoscopy
Endoscopy
If the Glasgow-Blatchford score is zero, the endoscopy is delayed as an outpatient
Intervention: Procedure: Endoscopy

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
208
64
December 2014
June 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • To be admitted in the university hospital for a gastrointestinal hemorrhage (vomiting of red or black blood or melena)

Exclusion Criteria:

  • Age under 18
  • Pregnancy
  • Hemorrhage during hospitalisation
  • red rectal bleeding
  • No consent signed
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01029626
09-091
No
Not Provided
Not Provided
Marc Girardin, University Hospital, Geneva
University Hospital, Geneva
Not Provided
Principal Investigator: Marc Girardin, MD Geneva University Hospital
University Hospital, Geneva
May 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP